{"id":395725,"date":"2020-12-08T13:03:32","date_gmt":"2020-12-08T18:03:32","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=395725"},"modified":"2020-12-08T13:03:32","modified_gmt":"2020-12-08T18:03:32","slug":"wolters-kluwer-targets-precision-dosing-with-tabula-rasa-healthcares-dosemerx-integration","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/wolters-kluwer-targets-precision-dosing-with-tabula-rasa-healthcares-dosemerx-integration\/","title":{"rendered":"Wolters Kluwer Targets Precision Dosing with Tabula Rasa HealthCare\u2019s DoseMeRx Integration"},"content":{"rendered":"

<\/p>\n

Wolters Kluwer Targets Precision Dosing with Tabula Rasa HealthCare\u2019s DoseMeRx Integration<\/b><\/p>\n

Sentri7\u2019s Antimicrobial Stewardship solution delivers personalized vancomycin dosing to enhance patient safety and support pharmacy, workflow <\/i><\/p>\n

WALTHAM, Mass.–(BUSINESS WIRE<\/a>)–Wolters Kluwer, Health<\/a>, a global provider of trusted clinical technology and evidence-based solutions, has announced the integration of DoseMeRx\u2122<\/a>, a Tabula Rasa Healthcare precision dosing solution, with Sentri7\u2019s Antimicrobial Stewardship<\/a> (AMS) solution. With a single click, pharmacists can review patient-specific parenteral vancomycin dose recommendations calculated automatically using key clinical data such as patient weight, laboratory values, creatinine levels and drug administration times. <\/b><\/p>\n

\n\u201cDosing and monitoring of vancomycin can be complex, requiring patient data and laboratory results to individualize the dose for each patient,\u201d said Charles Cornish, Executive Vice President, Hospitals Business Unit, TRHC. \u201cBy integrating our precision dosing platform with Wolters Kluwer\u2019s Sentri7 solution, pharmacists across the country will have convenient, integrated real-time Bayesian dosing support to align with the best practices in the American Society of Health System Pharmacists 2020 guideline<\/a> recommendation for dosing and monitoring of vancomycin.\u201d\n<\/p>\n

\nVancomycin is one of the most commonly used antibiotics in hospitals today. Traditionally, calculating vancomycin doses for patients requires coordination among pharmacists, nurses, and laboratory technicians, as well as manual calculations that are time-consuming. With the DoseMeRx integration, pharmacists have automated access to faster, more precise calculations, without any data entry, and proactively monitor for adjustments to reduce a patient\u2019s risk of acute kidney injury.\n<\/p>\n

\n\u201cPharmacists are routinely challenged by how best to avoid adverse drug events in patients. By improving the methodology for precision dosing, pharmacists can focus on delivering the best possible patient care,\u201d said Karen Kobelski, Vice President and General Manager, Clinical Surveillance, Compliance & Data Solutions at Wolters Kluwer, Health. \u201cWith the seamless transfer of patient specific parameters between Sentri7 and DoseMeRx, clinical teams have the expert solutions they need to predict more accurate drug concentration over time.\u201d\n<\/p>\n

\nIn addition to the DoseMeRx real-time vancomycin dosing platform, pharmacists can leverage Sentri7\u2019s evidence-based AMS rules to assess appropriate vancomycin use and keep prescribing in line with their hospital\u2019s antimicrobial stewardship goals and the CDC\u2019s Core Elements of Antimicrobial Stewardship<\/a> program.\n<\/p>\n

\nClick here to learn more about Sentri7\u2019s Antimicrobial Stewardship<\/a> (AMS) solution.\n<\/p>\n

About Wolters Kluwer <\/b><\/p>\n

\nWolters Kluwer (WKL) is a global leader in professional information, software solutions, and services for the clinicians, nurses, accountants, lawyers, and tax, finance, audit, risk, compliance, and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with advanced technology and services.\n<\/p>\n

\nWolters Kluwer reported 2019 annual revenues of \u20ac4.6 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.\n<\/p>\n

\nWolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students in effective decision-making and outcomes across healthcare. We support clinical effectiveness, learning and research, clinical surveillance and compliance, as well as data solutions. For more information about our solutions, visit https:\/\/www.wolterskluwer.com\/en\/health<\/a> and follow us on LinkedIn<\/a> and Twitter @WKHealth<\/a>.\n<\/p>\n

\nFor more information, visit www.wolterskluwer.com<\/a>, follow us on Twitter<\/a>, Facebook<\/a>, LinkedIn<\/a>, and YouTube<\/a><\/p>\n

About DoseMeRx<\/b><\/p>\n

DoseMeRx<\/a> is a Tabula Rasa HealthCare technology solution (NASDAQ: TRHC) developed specifically for clinical practice. The DoseMeRx clinical decision support solution empowers healthcare providers to optimize dosing of high-risk parenteral medications to streamline operations, reduce adverse drugs events, decrease costs and improve patient outcomes. For more information, visit doseme-rx.com<\/a><\/p>\n

About Tabula Rasa HealthCare <\/b><\/p>\n

\nTabula Rasa HealthCare (TRHC) provides medication safety solutions that empower healthcare professionals to optimize medication regimens and reduce medication-related risk, specifically targeting adverse drug events. TRHC\u2019s technology solutions, including DoseMeRx\u2122 and MedWise\u2122, improve patient outcomes, reduce hospitalizations, and lower healthcare costs. TRHC\u2019s extensive clinical tele-pharmacy network improves care for patients nationwide. Its solutions are trusted by health plans and pharmacies to help drive value-based payment results. For more information, visit TRHC.com<\/a>.\n<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20201208005991\/en\/<\/a><\/span><\/p>\n

Media:
\n<\/b>
Andr\u00e9 Rebelo
\n
Public Relations Manager
\n
Wolters Kluwer
\n
+1 781.392.2411
\n
andre.rebelo@wolterskluwer.com<\/a><\/p>\n

TRHC Media Contact:
\n<\/b>
Dianne Semingson
\n
dsemingson@trhc.com
\n<\/a>
T: (215) 870-0829\n<\/p>\n

\nTRHC Investor Contact:
\n
Frank Sparacino
\n
fsparacino@trhc.com
\n<\/a>
T: (866) 648-2767\n<\/p>\n

KEYWORDS:<\/b> Massachusetts United States North America<\/p>\n

INDUSTRY KEYWORDS:<\/b> Nursing Health Hospitals General Health Clinical Trials Pharmaceutical Biotechnology<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Wolters Kluwer Targets Precision Dosing with Tabula Rasa HealthCare\u2019s DoseMeRx Integration Sentri7\u2019s Antimicrobial Stewardship solution delivers personalized vancomycin dosing to enhance patient safety and support pharmacy, workflow WALTHAM, Mass.–(BUSINESS WIRE)–Wolters Kluwer, Health, a global provider of trusted clinical technology and evidence-based solutions, has announced the integration of DoseMeRx\u2122, a Tabula Rasa Healthcare precision dosing solution, with Sentri7\u2019s Antimicrobial Stewardship (AMS) solution. With a single click, pharmacists can review patient-specific parenteral vancomycin dose recommendations calculated automatically using key clinical data such as patient weight, laboratory values, creatinine levels and drug administration times. \u201cDosing and monitoring of vancomycin can be complex, requiring patient data and laboratory results to individualize the dose for each patient,\u201d said Charles Cornish, Executive Vice President, Hospitals Business … <\/p>\n

Continue reading “Wolters Kluwer Targets Precision Dosing with Tabula Rasa HealthCare\u2019s DoseMeRx Integration”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-395725","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nWolters Kluwer Targets Precision Dosing with Tabula Rasa HealthCare\u2019s DoseMeRx Integration - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/wolters-kluwer-targets-precision-dosing-with-tabula-rasa-healthcares-dosemerx-integration\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Wolters Kluwer Targets Precision Dosing with Tabula Rasa HealthCare\u2019s DoseMeRx Integration - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Wolters Kluwer Targets Precision Dosing with Tabula Rasa HealthCare\u2019s DoseMeRx Integration Sentri7\u2019s Antimicrobial Stewardship solution delivers personalized vancomycin dosing to enhance patient safety and support pharmacy, workflow WALTHAM, Mass.–(BUSINESS WIRE)–Wolters Kluwer, Health, a global provider of trusted clinical technology and evidence-based solutions, has announced the integration of DoseMeRx\u2122, a Tabula Rasa Healthcare precision dosing solution, with Sentri7\u2019s Antimicrobial Stewardship (AMS) solution. With a single click, pharmacists can review patient-specific parenteral vancomycin dose recommendations calculated automatically using key clinical data such as patient weight, laboratory values, creatinine levels and drug administration times. \u201cDosing and monitoring of vancomycin can be complex, requiring patient data and laboratory results to individualize the dose for each patient,\u201d said Charles Cornish, Executive Vice President, Hospitals Business … Continue reading "Wolters Kluwer Targets Precision Dosing with Tabula Rasa HealthCare\u2019s DoseMeRx Integration"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/wolters-kluwer-targets-precision-dosing-with-tabula-rasa-healthcares-dosemerx-integration\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-08T18:03:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201208005991r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wolters-kluwer-targets-precision-dosing-with-tabula-rasa-healthcares-dosemerx-integration\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wolters-kluwer-targets-precision-dosing-with-tabula-rasa-healthcares-dosemerx-integration\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Wolters Kluwer Targets Precision Dosing with Tabula Rasa HealthCare\u2019s DoseMeRx Integration\",\"datePublished\":\"2020-12-08T18:03:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wolters-kluwer-targets-precision-dosing-with-tabula-rasa-healthcares-dosemerx-integration\\\/\"},\"wordCount\":745,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wolters-kluwer-targets-precision-dosing-with-tabula-rasa-healthcares-dosemerx-integration\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201208005991r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wolters-kluwer-targets-precision-dosing-with-tabula-rasa-healthcares-dosemerx-integration\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wolters-kluwer-targets-precision-dosing-with-tabula-rasa-healthcares-dosemerx-integration\\\/\",\"name\":\"Wolters Kluwer Targets Precision Dosing with Tabula Rasa HealthCare\u2019s DoseMeRx Integration - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wolters-kluwer-targets-precision-dosing-with-tabula-rasa-healthcares-dosemerx-integration\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wolters-kluwer-targets-precision-dosing-with-tabula-rasa-healthcares-dosemerx-integration\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201208005991r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2020-12-08T18:03:32+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wolters-kluwer-targets-precision-dosing-with-tabula-rasa-healthcares-dosemerx-integration\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wolters-kluwer-targets-precision-dosing-with-tabula-rasa-healthcares-dosemerx-integration\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wolters-kluwer-targets-precision-dosing-with-tabula-rasa-healthcares-dosemerx-integration\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201208005991r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201208005991r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wolters-kluwer-targets-precision-dosing-with-tabula-rasa-healthcares-dosemerx-integration\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Wolters Kluwer Targets Precision Dosing with Tabula Rasa HealthCare\u2019s DoseMeRx Integration\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Wolters Kluwer Targets Precision Dosing with Tabula Rasa HealthCare\u2019s DoseMeRx Integration - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/wolters-kluwer-targets-precision-dosing-with-tabula-rasa-healthcares-dosemerx-integration\/","og_locale":"en_US","og_type":"article","og_title":"Wolters Kluwer Targets Precision Dosing with Tabula Rasa HealthCare\u2019s DoseMeRx Integration - Market Newsdesk","og_description":"Wolters Kluwer Targets Precision Dosing with Tabula Rasa HealthCare\u2019s DoseMeRx Integration Sentri7\u2019s Antimicrobial Stewardship solution delivers personalized vancomycin dosing to enhance patient safety and support pharmacy, workflow WALTHAM, Mass.–(BUSINESS WIRE)–Wolters Kluwer, Health, a global provider of trusted clinical technology and evidence-based solutions, has announced the integration of DoseMeRx\u2122, a Tabula Rasa Healthcare precision dosing solution, with Sentri7\u2019s Antimicrobial Stewardship (AMS) solution. With a single click, pharmacists can review patient-specific parenteral vancomycin dose recommendations calculated automatically using key clinical data such as patient weight, laboratory values, creatinine levels and drug administration times. \u201cDosing and monitoring of vancomycin can be complex, requiring patient data and laboratory results to individualize the dose for each patient,\u201d said Charles Cornish, Executive Vice President, Hospitals Business … Continue reading \"Wolters Kluwer Targets Precision Dosing with Tabula Rasa HealthCare\u2019s DoseMeRx Integration\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/wolters-kluwer-targets-precision-dosing-with-tabula-rasa-healthcares-dosemerx-integration\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-08T18:03:32+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201208005991r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wolters-kluwer-targets-precision-dosing-with-tabula-rasa-healthcares-dosemerx-integration\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wolters-kluwer-targets-precision-dosing-with-tabula-rasa-healthcares-dosemerx-integration\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Wolters Kluwer Targets Precision Dosing with Tabula Rasa HealthCare\u2019s DoseMeRx Integration","datePublished":"2020-12-08T18:03:32+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wolters-kluwer-targets-precision-dosing-with-tabula-rasa-healthcares-dosemerx-integration\/"},"wordCount":745,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wolters-kluwer-targets-precision-dosing-with-tabula-rasa-healthcares-dosemerx-integration\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201208005991r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wolters-kluwer-targets-precision-dosing-with-tabula-rasa-healthcares-dosemerx-integration\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/wolters-kluwer-targets-precision-dosing-with-tabula-rasa-healthcares-dosemerx-integration\/","name":"Wolters Kluwer Targets Precision Dosing with Tabula Rasa HealthCare\u2019s DoseMeRx Integration - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wolters-kluwer-targets-precision-dosing-with-tabula-rasa-healthcares-dosemerx-integration\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wolters-kluwer-targets-precision-dosing-with-tabula-rasa-healthcares-dosemerx-integration\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201208005991r1&sid=flmnd&distro=nx&lang=en","datePublished":"2020-12-08T18:03:32+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wolters-kluwer-targets-precision-dosing-with-tabula-rasa-healthcares-dosemerx-integration\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/wolters-kluwer-targets-precision-dosing-with-tabula-rasa-healthcares-dosemerx-integration\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wolters-kluwer-targets-precision-dosing-with-tabula-rasa-healthcares-dosemerx-integration\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201208005991r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201208005991r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wolters-kluwer-targets-precision-dosing-with-tabula-rasa-healthcares-dosemerx-integration\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Wolters Kluwer Targets Precision Dosing with Tabula Rasa HealthCare\u2019s DoseMeRx Integration"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/395725","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=395725"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/395725\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=395725"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=395725"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=395725"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}